NovoLog Mix 70/30

Novo Nordisk🇺🇸 United States

FDA Page

Effective Date: Feb 28, 2023
Approval ID: 1861fcee-7673-4afe-a206-08fa05c0add2
Products: 4 registered
Version: 24

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NOVOLOG MIX 70/30 safely and effectively. See full prescribing information for NOVOLOG MIX 70/30. NOVOLOG MIX 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, for subcutaneous useInitial U.S. Approval: 2001

Quick Stats

Total Products4

Labelers2

Label Sections31

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.